ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Bibliometric analysis and data visualization on drug delivery systems for infectious keratitis.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study aimed to conduct a bibliometric analysis of the research literature on drug delivery systems (DDS) for infectious keratitis from 2006 to 2025, presenting research trends, current hotspots, and collaboration patterns through visual maps.
methodsA systematic retrieval strategy was established to search and extract data from the Web of Science Core Collection database for studies on therapeutic DDS for keratitis between January 1, 2006, and December 31, 2025. GraphPad Prism, CiteSpace, AND VOSviewer were used to perform visualization analysis and evaluate the trends.
results(1) Over the 20-year period from 2006 to 2025, the number of publications and citations on DDS for infectious keratitis has continued to increase, rising from an initial annual output of less than 10 to over 50 papers in recent years. (2) A total of 60 countries and regions worldwide participated in these publications, with China ranking first with a total of 137 papers. Cairo University emerged as the most productive institution, with 29 papers. Soumyajit Majumdar contributed the most, with 11 papers in total. In terms of academic impact, China had the highest total citation count( 3,169), whereas the USA showed the highest betweenness centrality. (3) The"International Journal of Pharmaceutics" was the leading journal in this field, with the highest number of co-citations (360). (4) Co-occurrence and clustering analysis of high-frequency keywords revealed several major themes centered on drug delivery, nanoparticles, fungal keratitis, drug formulation, and sustained release. High-frequency keyword and clustering analyses highlighted sustained interest in nanoparticles, hydrogels, liposomes, in situ gels and 3D printing related delivery strategies.
conclusionThis bibliometric study covers two decades of research on the development and application of advanced DDS in the treatment of infectious keratitis. The field has attracted increasing global research attention, with China leading in publication output and the USA exerting greater academic influence. The current focus has shifted from traditional formulations to smart nanocarrier strategies. To achieve success, interdisciplinary collaboration is required to overcome the challenges of safety, production scalability, and clinical translation.
Indexed as
Identifiers
42171727What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.